Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Lu Li
Lu Li
Stock Analyst at UBS
(2.60)
# 2,150
Out of 4,711 analysts
3
Total ratings
100%
Success rate
12.45%
Average return
Main Sectors:
Healthcare
Top Industries:
Diagnostics & Research
Stocks Rated by Lu Li
Stock
Action
Price Target
Current
Upside
Ratings
Updated
MYGN
Myriad Genetics
Initiates:
Neutral
$18
$13.36
+34.73%
1
Dec 10, 2024
VCYT
Veracyte
Maintains:
Buy
$43
→
$46
$40.89
+12.50%
2
Nov 7, 2024
MYGN
Myriad Genetics
Dec 10, 2024
Initiates:
Neutral
Price Target:
$18
Current: $13.36
Upside:
+34.73%
1 Ratings
View All
VCYT
Veracyte
Nov 7, 2024
Maintains:
Buy
Price Target:
$43
→
$46
Current: $40.89
Upside:
+12.50%
2 Ratings
View All